The effect of adrenaline and of alpha- and beta-adrenergic blocking agents on ATP concentration and on incorporation of 32Pi into ATP in rat fat cells.
D000255:Adenosine Triphosphate / Q000096:biosynthesis / Q000378:metabolism*; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D004837:Epinephrine / Q000494:pharmacology*; D006593:Hexokinase / Q000494:pharmacology; D066298:In Vitro Techniques; D008156:Luciferases / Q000494:pharmacology; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology; D010758:Phosphorus / Q000378:metabolism; D010761:Phosphorus Radioisotopes; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010761:Phosphorus Radioisotopes; D010643:Phenoxybenzamine; D010758:Phosphorus; D000255:Adenosine Triphosphate; D011433:Propranolol; D008156:Luciferases; D006593:Hexokinase; D004837:Epinephrine